Suppr超能文献

一种用于选择头颈部癌症患者进行自适应放疗的有效策略。

An efficient strategy to select head and neck cancer patients for adaptive radiotherapy.

机构信息

University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, The Netherlands; Shantou University, Cancer Hospital of Shantou University Medical College, Department of Radiotherapy, China.

University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, The Netherlands.

出版信息

Radiother Oncol. 2023 Sep;186:109763. doi: 10.1016/j.radonc.2023.109763. Epub 2023 Jun 21.

Abstract

BACKGROUND AND PURPOSE

Adaptive radiotherapy (ART) is workload intensive but only benefits a subgroup of patients. We aimed to develop an efficient strategy to select candidates for ART in the first two weeks of head and neck cancer (HNC) radiotherapy.

MATERIALS AND METHODS

This study retrospectively enrolled 110 HNC patients who underwent modern photon radiotherapy with at least 5 weekly in-treatment re-scan CTs. A semi auto-segmentation method was applied to obtain the weekly mean dose (D) to OARs. A comprehensive NTCP-profile was applied to obtain NTCP's. The difference between planning and actual values of D (ΔD) and dichotomized difference of clinical relevance (BIOΔNTCP) were used for modelling to determine the cut-off maximum ΔD of OARs in week 1 and 2 (maxΔD and maxΔD). Four strategies to select candidates for ART, using cut-off maxΔD were compared.

RESULTS

The Spearman's rank correlation test showed significant positive correlation between maxΔD and BIOΔNTCP (p-value <0.001). For major BIOΔNTCP (>5%) of acute and late toxicity, 10.9% and 4.5% of the patients were true candidates for ART. Strategy C using both cut-off maxΔD (3.01 and 5.14 Gy) and cut-off maxΔD (3.41 and 5.30 Gy) showed the best sensitivity, specificity, positive and negative predictive values (0.92, 0.82, 0.38, 0.99 for acute toxicity and 1.00, 0.92, 0.38, 1.00 for late toxicity, respectively).

CONCLUSIONS

We propose an efficient selection strategy for ART that is able to classify the subgroup of patients with >5% BIOΔNTCP for late toxicity using imaging in the first two treatment weeks.

摘要

背景与目的

自适应放疗(ART)工作量大,但仅使一部分患者受益。我们旨在开发一种有效的策略,以在头颈部癌症(HNC)放疗的前两周选择接受 ART 的患者。

材料与方法

本研究回顾性纳入 110 例接受现代光子放疗且至少有 5 次每周治疗再扫描 CT 的 HNC 患者。采用半自动分割方法获取 OAR 的每周平均剂量(D)。应用综合 NTCP 预测模型获取 NTCP 值。采用 D 的计划值与实际值的差值(ΔD)和有临床意义的二分差(BIOΔNTCP)进行建模,以确定第 1 周和第 2 周 OAR 的最大 ΔD 截止值(maxΔD 和 maxΔD)。比较了 4 种使用截断 maxΔD 选择 ART 候选者的策略。

结果

Spearman 秩相关检验显示 maxΔD 与 BIOΔNTCP 之间存在显著正相关(p 值<0.001)。对于急性和晚期毒性的主要 BIOΔNTCP(>5%),10.9%和 4.5%的患者是 ART 的真正候选者。使用截断 maxΔD(3.01 和 5.14 Gy)和截断 maxΔD(3.41 和 5.30 Gy)的策略 C 显示出最佳的敏感性、特异性、阳性和阴性预测值(急性毒性分别为 0.92、0.82、0.38、0.99,晚期毒性分别为 1.00、0.92、0.38、1.00)。

结论

我们提出了一种有效的 ART 选择策略,能够在前两周的治疗中通过影像学将晚期毒性 BIOΔNTCP>5%的患者分类。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验